News search

Keyword

Locations

News type

Sectors

Services

Transformations

AI, Data and Transformative Technologies

Osborne Clarke advises Expedition Growth Capital on EUR 11 million growth investment in AI workforce management platform Nesto

14/04/2026

• 2 mins

Life Sciences and Healthcare

Osborne Clarke advises CoaguSense on acquisition of DOASENSE DOAC testing business

09/04/2026

• 2 mins

Corporate

Osborne Clarke advises shareholders of fija finance GmbH on acquisition by Keyrock

08/04/2026

• 1 min

Life Sciences and Healthcare

Osborne Clarke advises neuroClues® on €10 million Series A fundraising to bring AI powered neurological biomarkers across Europe and prepare U.S. entry

08/04/2026

• 1 min

Corporate

Osborne Clarke EC/VC team advises Irresistible Materials on strategic investment by TOK

07/04/2026

• 1 min

Banking and finance

Osborne Clarke advises Ulixes SGR on the structuring and establishment of the new Lumen II fund

03/04/2026

• 1 min

Corporate

Rafał Kozłowski appointed Partner in the Corporate and M&A practice and Head of the Emerging Companies and Growth Capital team at Osborne Clarke’s Warsaw office

02/04/2026

• 3 mins

Corporate

UK Pay Gap Reporting

29/04/2021

• 1 min

Legal Notice

When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, click here.

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

News search

Osborne Clarke advises Expedition Growth Capital on EUR 11 million growth investment in AI workforce management platform Nesto

Osborne Clarke advises CoaguSense on acquisition of DOASENSE DOAC testing business

Osborne Clarke advises shareholders of fija finance GmbH on acquisition by Keyrock

Osborne Clarke advises neuroClues® on €10 million Series A fundraising to bring AI powered neurological biomarkers across Europe and prepare U.S. entry

Osborne Clarke EC/VC team advises Irresistible Materials on strategic investment by TOK

Osborne Clarke advises Ulixes SGR on the structuring and establishment of the new Lumen II fund

Rafał Kozłowski appointed Partner in the Corporate and M&A practice and Head of the Emerging Companies and Growth Capital team at Osborne Clarke’s Warsaw office

UK Pay Gap Reporting

Sign up for our newsletter

Legal Notice